Fidelity International
TMDX icon

Fidelity International’s Transmedics TMDX Stock Holding History

Fidelity International’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,055,553
Closed -$141M – 1054
2025
Q2 		$141M Sell
1,055,553
-170,420
-14% -$18.7M 0.12% 185
2025
Q1 		$82.5M Buy
1,225,973
+225,615
+23% +$15.5M 0.08% 251
2024
Q4 		$62.4M Buy
1,000,358
+218,961
+28% +$20.4M 0.06% 276
2024
Q3 		$123M Buy
781,397
+404,560
+107% +$62.3M 0.11% 203
2024
Q2 		$56.8M Buy
376,837
+215,951
+134% +$25.9M 0.06% 296
2024
Q1 		$11.9M Buy
160,886
+155,886
+3,118% +$12.8M 0.01% 499
2023
Q4 		$395K Buy
+5,000
New +$302K ﹤0.01% 741
2022
Q4 		– Sell
-154,608
Closed -$6.45M – 868
2022
Q3 		$6.45M Sell
154,608
-122,859
-44% -$5.34M 0.01% 550
2022
Q2 		$8.73M Sell
277,467
-1,727
-0.6% -$46.1K 0.01% 518
2022
Q1 		$7.52M Buy
+279,194
New +$5M 0.01% 563

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity International's TMDX Position: Q3 2025 in Review

Fidelity International sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 1,055,553 shares — an estimated $141M sold.

Fidelity International first reported a position in TMDX in Q1 2022 and held it in 10 quarters. The position peaked at $141M in Q2 2025. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Fidelity International reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • Fidelity International sold 1,055,553 Transmedics shares in Q3 2025, an estimated $141M.
  • Fidelity International first reported a position in Transmedics in Q1 2022 and held it in 10 quarters.
  • Fidelity International's Transmedics position peaked at $141M in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.